Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
183 | 3 | NOONAN SYNDROME//PTEN//CELL BIOLOGY | 56293 |
1016 | 2 | PTEN//MTOR//PI3K | 10616 |
4527 | 1 | PIK3CA//PI3K INHIBITOR//PI3K | 1801 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | PIK3CA | authKW | 1158745 | 10% | 37% | 177 |
2 | PI3K INHIBITOR | authKW | 740966 | 4% | 55% | 77 |
3 | PI3K | authKW | 497947 | 15% | 11% | 266 |
4 | P110 ALPHA | authKW | 487142 | 2% | 80% | 35 |
5 | PI3K ALPHA | authKW | 241338 | 1% | 69% | 20 |
6 | PIK3CA MUTATION | authKW | 224170 | 2% | 41% | 31 |
7 | P110 BETA | authKW | 203603 | 1% | 73% | 16 |
8 | BEZ235 | authKW | 183707 | 1% | 50% | 21 |
9 | ZSTK474 | authKW | 163304 | 1% | 67% | 14 |
10 | NVP BEZ235 | authKW | 160738 | 1% | 44% | 21 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 20965 | 56% | 0% | 1003 |
2 | Chemistry, Medicinal | 2840 | 12% | 0% | 222 |
3 | Cell Biology | 1548 | 17% | 0% | 298 |
4 | Biochemistry & Molecular Biology | 463 | 17% | 0% | 312 |
5 | Pathology | 285 | 4% | 0% | 75 |
6 | Chemistry, Organic | 215 | 7% | 0% | 118 |
7 | Pharmacology & Pharmacy | 210 | 9% | 0% | 160 |
8 | Genetics & Heredity | 74 | 4% | 0% | 75 |
9 | Hematology | 53 | 2% | 0% | 45 |
10 | Medicine, Research & Experimental | 43 | 3% | 0% | 56 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | HIGH THROUGHPUT SCREENING MOL PHARMACOL | 95263 | 0% | 78% | 7 |
2 | CANC METAB DMPK | 69992 | 0% | 100% | 4 |
3 | ORIGINAL NEW DRUGS DESIGN DISCOVERY | 67482 | 0% | 43% | 9 |
4 | CANC METAB BIOL | 55992 | 0% | 80% | 4 |
5 | CANC METAB CHEM | 55992 | 0% | 80% | 4 |
6 | SMALL MOL TRANSLAT ONCOL | 52494 | 0% | 100% | 3 |
7 | ONCOL DIS AREA | 51624 | 1% | 27% | 11 |
8 | STRUCT BIOL MOL MODELING | 39369 | 0% | 75% | 3 |
9 | ONCOL BIOMARKER DEV | 36486 | 1% | 19% | 11 |
10 | BIOL ONCOL DRUG DISCOVERY | 34996 | 0% | 100% | 2 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | MOLECULAR CANCER THERAPEUTICS | 11195 | 3% | 1% | 52 |
2 | CLINICAL CANCER RESEARCH | 7596 | 5% | 1% | 82 |
3 | ONCOTARGET | 6266 | 4% | 0% | 77 |
4 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 3611 | 4% | 0% | 74 |
5 | CANCER CELL | 2796 | 1% | 1% | 16 |
6 | CANCER DISCOVERY | 2708 | 0% | 2% | 9 |
7 | BREAST CANCER RESEARCH | 2500 | 1% | 1% | 18 |
8 | ACS MEDICINAL CHEMISTRY LETTERS | 2294 | 1% | 1% | 14 |
9 | CANCER RESEARCH | 1840 | 4% | 0% | 66 |
10 | ONCOGENE | 1238 | 2% | 0% | 37 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PIK3CA | 1158745 | 10% | 37% | 177 | Search PIK3CA | Search PIK3CA |
2 | PI3K INHIBITOR | 740966 | 4% | 55% | 77 | Search PI3K+INHIBITOR | Search PI3K+INHIBITOR |
3 | PI3K | 497947 | 15% | 11% | 266 | Search PI3K | Search PI3K |
4 | P110 ALPHA | 487142 | 2% | 80% | 35 | Search P110+ALPHA | Search P110+ALPHA |
5 | PI3K ALPHA | 241338 | 1% | 69% | 20 | Search PI3K+ALPHA | Search PI3K+ALPHA |
6 | PIK3CA MUTATION | 224170 | 2% | 41% | 31 | Search PIK3CA+MUTATION | Search PIK3CA+MUTATION |
7 | P110 BETA | 203603 | 1% | 73% | 16 | Search P110+BETA | Search P110+BETA |
8 | BEZ235 | 183707 | 1% | 50% | 21 | Search BEZ235 | Search BEZ235 |
9 | ZSTK474 | 163304 | 1% | 67% | 14 | Search ZSTK474 | Search ZSTK474 |
10 | NVP BEZ235 | 160738 | 1% | 44% | 21 | Search NVP+BEZ235 | Search NVP+BEZ235 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |